Excimer Laser-Assisted Angioplasty for In-Stent Restenosis of the Right Coronary Artery in a Diabetic Patient: A

Vasavdatta Sharma1, Tom Devasia1, Monika Jawanjal1

  • 1Department of Cardiology Kasturba Medical College, Manipal India.

Clinical Case Reports
|September 24, 2025
PubMed

Insights

This case study highlights excimer laser use for complex in-stent restenosis (ISR) in a diabetic patient with coronary artery disease. Advanced techniques like laser-assisted percutaneous coronary intervention (PCI) enabled successful treatment.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Devices

Background:

  • In-stent restenosis (ISR) remains a challenge after percutaneous coronary interventions (PCIs).
  • Heavily calcific lesions complicate revascularization strategies.
  • Diabetic patients often present with complex coronary artery disease.

Purpose of the Study:

  • To present a case of successful laser-assisted PCI for complex ISR.
  • To demonstrate the utility of excimer laser in managing challenging restenotic lesions.
  • To emphasize tailored treatment approaches for ISR.

Main Methods:

  • Coronary angiography to diagnose ISR.
  • Excimer laser atherectomy for lesion preparation.
  • Drug-eluting stent (DES) implantation.
  • Intravascular ultrasound (IVUS) guidance for optimal stent deployment.

Main Results:

  • Successful revascularization of the right coronary artery (RCA) ISR.
  • Resolution of exertional angina symptoms.
  • Demonstrated feasibility of laser use in complex calcific ISR.

Conclusions:

  • Excimer laser is a valuable tool for treating complex ISR.
  • IVUS guidance enhances procedural success in challenging PCI cases.
  • Individualized treatment strategies are crucial for managing ISR in diabetic patients.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
215
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
220
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
245
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
812
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
237